Skip to main content
KMB logo

Kimberly-Clark Corporation (KMB) Stock Price & Analysis

Kimberly-Clark Corporation (KMB) — MoonshotScore 79/100 (Strong band), calculated Nov 18, 2026. Price $105.25 (-1.86%), as of the Nov 19, 2026 trading session; market cap $64.6B. Expected results Jan 26, 2027.

Listing-status flag — 8-K Item 3.01, filed May 19, 2025.

Educational signal · not a buy or sell recommendation · How to read this

$105.25 −$1.99 (-1.86%) Market Cap $64.6B

Kimberly-Clark Corporation · KMB · NASDAQ · Consumer Defensive · Household & Personal Products

Research dated 2026-09-12: Kimberly-Clark sells branded diapers, adult and feminine care, consumer tissue, and professional hygiene products through retailers, distributors, facilities, and e-commerce. Diapers carry the largest product exposure, so this is not merely a tissue company. Steady cash generation now has to offset a sharp annual sales contraction, profit pressure below gross profit, and debt far above liquid resources.

Price as of Nov 19, 2026

Key Statistics

79 of 100

MoonshotScore v2 · Kimberly-Clark (KMB)

Strong
Business Quality Elite (95)
Financial Safety Sound (63)
Valuation Full (44)
Growth Durability Fading (34)
Momentum Rising (71)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Elite quality, but weak growth and a full valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Sound; Valuation: Full; Growth Durability: Fading; Momentum: Rising.

  • quarterly revenue $4.15B (Q3 FY2025, quarter ended Sep 2025)
  • EPS beat 0 of the last 4 reports
  • expected results Jan 26, 2027

Holding back: soft growth

Helping: business quality, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for KMB (58 recorded, newest six shown)
RecordedScoreBand
72Strong
73Strong
73Strong
79Strong
79Strong
79Strong

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$105.25
Change on the day-1.86%
52-week range$92.42–$116.82
Market capitalisation$64.6B—
Price / earnings (trailing)10.89
Shares traded on the day7.23M
Beta (volatility vs the S&P 500)0.28

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 19, 2026: low $94, high $121, latest $105. $121 $94 high $121 Oct 17, 2025 Nov 19, 2026 · $105 $121Oct 17, 2025$120Oct 31, 2025$104Nov 14, 2025$109Nov 28, 2025$103Dec 12, 2025$101Dec 26, 2025$98Jan 9, 2026$102Jan 23, 2026$104Feb 6, 2026$109Feb 20, 2026$105Mar 6, 2026$98Mar 20, 2026$96Apr 2, 2026$99Apr 17, 2026$98May 1, 2026$96May 15, 2026$98May 29, 2026$102Jun 12, 2026$109Jun 26, 2026$112Jul 10, 2026$110Jul 24, 2026$110Aug 7, 2026$109Aug 21, 2026$105Sep 4, 2026$98Sep 18, 2026$94Oct 2, 2026$106Oct 16, 2026$108Oct 30, 2026$109Nov 13, 2026

Point at or tab to any week for its close.

Other perspectives

Council score for Kimberly-Clark (KMB): perspectives

Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.

5-Factor Breakdown

Business Quality Strong
Financial Safety Moderate
Valuation Neutral
Growth Durability Weak
Momentum Moderate

Legends Council

6 lenses, 6 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Neutral read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Neutral read

Read on: Nov 20, 2026

Munger's Mindset

Balance Sheet & Valuation

Financial Health Weak
Margin of Safety Fairly Valued
Profit Margin Moderate
Revenue Growth Negative
Debt/Equity Negative
ROE Strong
Gross Margin Neutral

Read on: Nov 20, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

One of these lenses reads this company less favourably than the MoonshotScore does: Financial health lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.

The Munger lens reads the current price as fairly valued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is Kimberly-Clark (KMB), and what does it report?

Short answer · as of

The economic engine is repeated replenishment of Huggies, Pull-Ups, Kotex, Poise, Depend, Kleenex, Scott, Cottonelle, Viva, and related products.

Household purchases flow through retailers and e-commerce, while professional products reach manufacturers, lodging operators, offices, food-service sites, and public facilities.

Operational reporting separates North America from International Personal Care, while the product view separates diapers, adult care, feminine care, consumer tissue, and professional products. North America contains personal care alongside tissue and professional hygiene; the international operation is concentrated on personal care.

2 · Latest results

What do the latest results show for Kimberly-Clark (KMB)?

Short answer · as of

The most recent reported quarter, Q3 FY2025, carried revenue of $4.15B.

Revenue edged higher from the preceding period and the comparable period, while gross profit also improved. That progress did not reach the bottom line: selling and administrative expense increased, operating profit weakened, and net income and diluted earnings fell sharply.

The latest release missed consensus for revenue and earnings after earnings had repeatedly exceeded expectations. The observable pressure sits below gross profit, but the results alone do not establish why those costs rose.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026Not availableNot availableNot availableNot available
Jun 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2025$4.15B$446M$1.34 (diluted)
Q4 FY2025$4.08B$499M$1.50 (diluted)
Q1 FY2026$4.16B$665M$2.00 (diluted)
Q2 FY2026$4.19B$345M$1.04 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Kimberly-Clark (KMB)?

Short answer

Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.

Operating cash flow remained positive throughout the reported quarterly series and generally covered capital spending with room left over. The latest period also rebuilt cash and short-term investments substantially, although the closing balance remained below the beginning of the reported window.

Debt stands far above cash and investments, liabilities are substantial, and short-term liquidity ratios remain below full coverage. Regular dividend payments and capital investment therefore compete with debt obligations for the cash generated by everyday product sales.

Profitability and distress screens remain supportive, but elevated leverage makes continued cash conversion more important than the unusually high return on equity might imply.

4 · What to check next?

What should you watch next at Kimberly-Clark (KMB)?

Short answer · as of

The next earnings report is expected on Jan 26, 2027.

At the scheduled earnings release, watch whether sales remain near their recent quarterly range and whether improving gross profit can again reach operating profit. Selling and administrative expense is the immediate bridge between those lines, while another consensus miss would reinforce the break from the earlier earnings pattern.

Cash conversion also deserves attention: operating cash flow relative to capital spending, the direction of liquid resources, and any reduction in the gap between debt and cash. The distant consensus series contains an abrupt revenue reset far above the recent annual run rate, which becomes meaningful only if reported segment sales establish the change.

Any formal update tied to the continued-listing rule notice warrants attention alongside the periodic filings.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The newest quarter held here (Q3 FY2025) was filed Oct 30, 2025 — 12 months ago.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Kimberly-Clark compare with its peers?

Short answer

Kimberly-Clark's score ranks 9th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Kimberly-Clark combines recurring personal-care purchases with consumer tissue and a professional hygiene channel. A tissue-only comparison misses the largest product exposure, while a personal-care-only comparison leaves out household paper products and demand from workplaces, lodging, food service, manufacturing, and public facilities.

The reporting structure also matters: North America carries the broader portfolio, whereas the international segment centers on personal care. Regional performance therefore reflects a different product mix rather than merely the same portfolio sold in different places.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Inter Parfums, Inc. (IPAR) Same industry, near in market value$132.94 Nov 19, 2026$4.26B96 5-pillar Nov 18, 2026
Ambev S.A. (ABEV) Named competitor$2.66 Nov 19, 2026$41.0B94 5-pillar Nov 18, 2026
Colgate-Palmolive Company (CL) Same industry, near in market value$96.88 Nov 19, 2026$77.0B93 5-pillar Nov 18, 2026
Unilever PLC (UL) Same industry, near in market value$63.36 Nov 19, 2026$136B88 5-pillar Nov 18, 2026
The Procter & Gamble Company (PG) Same industry, near in market value$167.85 Nov 19, 2026$389B88 5-pillar Nov 18, 2026
The Hershey Company (HSY) Named competitor$174.05 Nov 19, 2026$35.0B86 5-pillar Nov 18, 2026
e.l.f. Beauty, Inc. (ELF) Same industry, near in market value$108.93 Nov 19, 2026$6.44B84 5-pillar Nov 18, 2026
Church & Dwight Co., Inc. (CHD) Same industry, near in market value$109.68 Nov 19, 2026$25.9B82 5-pillar Nov 18, 2026
Kimberly-Clark (KMB) — this page$105.25$64.6B79
The Estée Lauder Companies Inc. (EL) Same industry, near in market value$101.77 Nov 19, 2026$36.9B64 5-pillar Nov 18, 2026
The Clorox Company (CLX) Same industry, near in market value$104.90 Nov 19, 2026$12.7B60 5-pillar Nov 18, 2026
Somnigroup International Inc (SGI) Same industry, near in market value$59.44 Nov 19, 2026$13.7B58 5-pillar Nov 18, 2026
JBS N.V. (JBS) Named competitor$11.86 Nov 19, 2026$12.7B57 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Consumer Defensive stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Last captured analyst target range, low to high (expired, captured Nov 18, 2026)
$105.00 – $120.00
Last captured analyst target (expired, captured Nov 18, 2026)
$114.20
Last captured median analyst target (expired, captured Nov 18, 2026)
$115.00

Historical target record · Captured · Capture expired; not a current watchpoint.

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Nov 2, 2026

Transactions
22
Identified insiders
10
Purchases
0
Sales
0
Other transactions
22

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held KMB in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported KMB in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Kimberly-Clark (KMB)?

Read these with our analysis →

KMB Consumer Defensive Stock FAQ

The last 2 questions are answered from this page's own dated data, not from the research.

Why do Huggies and adult-care products matter to Kimberly-Clark?

Diapers generate more revenue than any other disclosed product category, while adult care adds a distinct replenishment market through Depend, Poise, and related brands.

Why can stronger Kleenex and tissue economics fail to lift Kimberly-Clark operating profit?

Gross profit improved in the latest period, but higher selling and administrative expense coincided with weaker operating profit and net income. Improvement at the product margin level must survive the cost structure below it.

What does International Personal Care include at Kimberly-Clark?

The segment sells baby and child care, adult care, and feminine care products under brands including Huggies, Kotex, Depend, Goodfeel, and Intimus. Consumer tissue and professional hygiene sit within the broader North American operation.

Can Kimberly-Clark support its dividend while carrying substantial debt?

Recent operating cash flow has covered capital spending, and dividend payments have remained regular. Debt remains far above liquid resources, so continued cash conversion is central to preserving that flexibility.

What is the KMB stock price today?

The last price recorded for Kimberly-Clark Corporation (KMB), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the KMB price target?

The last analyst consensus price target we captured for Kimberly-Clark Corporation (KMB), with its FMP capture date, is listed under Analyst targets & estimates on this page. That capture has expired, so read it as historical, not as a current target. Targets are analyst opinions, not a Stock Expert AI forecast.

Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 26 figures on this page — 2 from SEC filings and earnings calls, 21 from Financial Modeling Prep (FMP), 2 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-12), by section of the research

  • Summary at the top of the page: Business description; Sector / industry (provider taxonomy); Revenue by segment; Annual revenue and net result (USD millions); Operating cash flow by quarter (USD millions); Cash, investments and debt
  • 1. What is Kimberly-Clark (KMB), and what does it report?: Business description; Revenue by segment; Sector / industry (provider taxonomy)
  • 2. What do the latest results show for Kimberly-Clark (KMB)?: Quarterly income statement (USD thousands); Annual revenue and net result (USD millions); Reported versus estimated, last 8 quarters; Most recent periodic reports; Recent SEC filings
  • 3. What are the financial strengths and risks for Kimberly-Clark (KMB)?: Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and investment components; Cash and short-term investments over time (USD millions); Cash decline over the reported window; Cash against market value; Trailing twelve-month ratio set; Distress and quality screens; Recent dividends paid; Next scheduled dividend
  • 4. What should you watch next at Kimberly-Clark (KMB)?: Next earnings report; Reported versus estimated, last 8 quarters; Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Cash and short-term investments over time (USD millions); Cash against market value; Analyst revenue and earnings estimates (average); Annual revenue and net result (USD millions); Revenue by segment; Continued-listing rule notice; Recent SEC filings
  • 5. How does Kimberly-Clark compare with its peers?: Business description; Sector / industry (provider taxonomy); Revenue by segment
  • FAQ: Why do Huggies and adult-care products matter to Kimberly-Clark?: Business description; Revenue by segment
  • FAQ: Why can stronger Kleenex and tissue economics fail to lift Kimberly-Clark operating profit?: Quarterly income statement (USD thousands); Business description
  • FAQ: What does International Personal Care include at Kimberly-Clark?: Business description; Revenue by segment
  • FAQ: Can Kimberly-Clark support its dividend while carrying substantial debt?: Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash against market value; Recent dividends paid; Next scheduled dividend
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.

ETFs that hold KMB

Funds in our ETF coverage that list KMB among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.

ETFWeightHoldings as of
VictoryShares Dividend Accelerator ETF (VSDA)2.98%
Xtrackers S&P Dividend Aristocrats Screened ETF (SNPD)1.99%